Peroral active agent suspension

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/5415 (2006.01) A61K 9/00 (2006.01) A61K 9/10 (2006.01) A61K 31/10 (2006.01) A61K 31/145 (2006.01) A61K 31/18 (2006.01) A61K 31/19 (2006.01) A61K 47/02 (2006.01)

Patent

CA 2326048

The present invention relates to orally administered suspensions of pharmaceutical active substances of the NSAID type, particularly the antirheumatic agent meloxicam, which are stabilised by the addition of small amounts of highly dispersed silicon dioxide using high shear forces and adding small amounts of hydrophilic polymers to form a three-dimensional siloid structure, and a process for the preparation thereof.

L'invention concerne des suspensions à administrer par voie buccale, de principes actifs pharmaceutiques de type AINS, notamment le Meloxicam, agent antirhumatismal, qui sont stabilisées par introduction de faibles quantités de dioxyde de silicium fortement dispersé, au moyen de forces de cisaillement élevées et par adjonction de faibles quantités de polymères hydrophiles, pour former une structure siloïde tridimensionnelle. L'invention concerne en outre un procédé permettant de les utiliser.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Peroral active agent suspension does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Peroral active agent suspension, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Peroral active agent suspension will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1938336

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.